GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Icares Medicus 6612.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

69.70

+1.75%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.13bn

FY2016FY2025

Net income

TWD 51.2m

FY2016FY2025

Free cash flow

−TWD 112.3m

FY2016FY2025

Shareholders' equity

TWD 1.83bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.13bnTWD 859.8mTWD 605.5mTWD 511.9mTWD 393.9mTWD 362.7mTWD 419.4mTWD 329.3mTWD 266.1mTWD 246.3m
Gross profitTWD 668.2mTWD 599.7mTWD 482.4mTWD 417.4mTWD 322.9mTWD 291.9mTWD 331.8mTWD 234.6mTWD 204.6mTWD 173.4m
Research and developmentTWD 158.9mTWD 192.7mTWD 177.4mTWD 133.1mTWD 104.9mTWD 98.2mTWD 91.2mTWD 41.2mTWD 39.8mTWD 38.1m
Operating income—TWD 129.1mTWD 130.5mTWD 146.1mTWD 77.2mTWD 73.5mTWD 118.1mTWD 88.8mTWD 63.5mTWD 40.6m
Net incomeTWD 51.2mTWD 103.1mTWD 97.7mTWD 128.9mTWD 58.6mTWD 51.9mTWD 81.0mTWD 70.5mTWD 31.2mTWD 19.3m
Diluted earnings per share1.072.152.813.761.731.541.691.470.650.56

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 3.18bnTWD 3.01bnTWD 1.91bnTWD 1.04bnTWD 965.9mTWD 848.0mTWD 792.1mTWD 617.4mTWD 401.5mTWD 422.3m
Cash and short-term investments——TWD 968.4mTWD 426.9mTWD 373.6mTWD 281.3m———TWD 244.3m
Total liabilitiesTWD 1.21bnTWD 1.25bnTWD 239.8mTWD 105.6mTWD 145.0mTWD 145.6mTWD 139.0mTWD 46.0mTWD 64.9mTWD 119.2m
DebtTWD 110.0mTWD 326.4mTWD 121.6mTWD 6.2mTWD 17.5mTWD 23.3mTWD 3.0mTWD 3.1mTWD 32.8mTWD 83.9m
Shareholders' equityTWD 1.83bnTWD 1.66bnTWD 1.58bnTWD 878.7mTWD 746.8mTWD 665.8mTWD 623.5mTWD 570.1mTWD 335.7mTWD 303.1m
Shares outstanding48m48m35m34m34m34m48m48m48m34m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 58.8m−TWD 48.5m−TWD 25.8mTWD 128.9mTWD 38.6mTWD 71.4mTWD 88.8mTWD 63.2mTWD 45.5mTWD 27.5m
Capital spending−TWD 53.5m−TWD 156.7m−TWD 76.5m−TWD 34.0m−TWD 6.5m−TWD 11.2m−TWD 93.4m−TWD 6.1m−TWD 8.4m−TWD 3.7m
Free cash flow−TWD 112.3m−TWD 205.2m−TWD 102.3mTWD 94.9mTWD 32.1mTWD 60.2m−TWD 4.6mTWD 57.1mTWD 37.0mTWD 23.8m
Dividends paid−TWD 12.9m−TWD 7.8m−TWD 34.2m−TWD 17.0m−TWD 3.4m−TWD 16.9m−TWD 16.8m−TWD 15.1m−TWD 15.1m—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 347.7mTWD 298.6mTWD 300.6mTWD 263.6mTWD 269.2mTWD 297.6mTWD 256.9mTWD 257.0m
Gross profitTWD 181.2mTWD 166.6mTWD 190.5mTWD 183.7mTWD 160.4mTWD 172.3mTWD 172.8mTWD 159.8m
Operating incomeTWD 35.9mTWD 38.0mTWD 31.0mTWD 2.0mTWD 28.8mTWD 58.3m—TWD 32.0m
Net incomeTWD 34.3mTWD 38.3mTWD 18.6mTWD 2.4m−TWD 17.0mTWD 47.3mTWD 30.7mTWD 33.3m
Diluted earnings per share0.720.800.390.05-0.360.990.640.69
Cash from operationsTWD 51.0m−TWD 5.0m−TWD 4.0m−TWD 82.0mTWD 109.0m−TWD 81.0mTWD 86.0m−TWD 37.0m
Capital spending−TWD 13.0m−TWD 13.0m−TWD 7.0m−TWD 10.0m−TWD 20.0m−TWD 14.0m−TWD 96.0m−TWD 31.0m
Free cash flowTWD 38.0m−TWD 18.0m−TWD 11.0m−TWD 92.0mTWD 89.0m−TWD 95.0m−TWD 10.0m−TWD 68.0m
Total assetsTWD 3.20bnTWD 3.20bnTWD 3.18bnTWD 3.14bnTWD 3.01bnTWD 3.10bnTWD 3.01bnTWD 2.92bn
DebtTWD 48.2mTWD 101.8mTWD 110.0mTWD 119.8mTWD 146.6mTWD 270.7mTWD 326.4mTWD 341.4m
Shareholders' equityTWD 1.90bnTWD 1.88bnTWD 1.83bnTWD 1.75bnTWD 1.60bnTWD 1.72bnTWD 1.66bnTWD 1.58bn

Financial ratios

Data as of 23 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin72.3%69.8%79.7%81.6%82.0%80.5%
Operating margin8.1%21.3%21.6%28.5%19.6%20.3%
Net margin4.5%12.0%16.1%25.2%14.9%14.3%
Return on equity2.8%6.2%6.2%14.7%7.8%7.8%
Return on assets1.6%3.4%5.1%12.4%6.1%6.1%
Free cash flow yield—3.3%2.1%6.8%1.9%3.5%
Revenue growth31.5%42.0%18.3%29.9%8.6%-13.5%
Earnings growth-50.3%5.5%-24.2%120.0%12.9%-35.9%
Current ratio2.04x2.46x10.45x7.11x4.81x6.67x
Debt to equity0.06x0.20x0.01x0.01x0.02x0.02x
Equity ratio57.7%55.2%82.7%84.2%77.3%78.5%
Interest coverage3.80x9.97x18.20x253.66x93.10x75.34x
R&D as a share of sales14.1%22.4%29.3%26.0%26.6%27.1%
Buybacks as a share of market value—-37.8%-1.4%-1.0%-0.7%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue30.2%25.5%17.9%
Net income-26.5%-0.3%11.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin63.7%69.7%72.0%72.5%
Net margin7.8%12.3%12.7%13.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings62.847.633.716.029.630.038.130.659.764.6
Price to sales2.85.75.44.04.44.37.46.57.05.0

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 22 Aug 2025.

FY2025FY2024FY2023FY2022
Paid in the year0.2730.1650.7410.371
  • 1100-for-1000 split · 22 Aug 2025
  • 1100-for-1000 split · 21 Aug 2025
  • 1100-for-1000 split · 8 Jul 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.